Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster

Matteo Ruggeri; Silvia Coretti; Federica Romano; Americo Cicchetti

Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster

Matteo Ruggeri
, Silvia Coretti
, Federica Romano
, Americo Cicchetti

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

XZostavax vaccine is cost effective

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	International Journal of Technology Assessment in Health Care
Volume	32
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Economic evaluation

Cite this

@article{64aedee02b4a4adba15b013e831137fd,

title = "Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster",

abstract = "XZostavax vaccine is cost effective",

keywords = "Economic evaluation, Economic evaluation",

author = "Matteo Ruggeri and Silvia Coretti and Federica Romano and Americo Cicchetti",

year = "2016",

language = "English",

volume = "32",

pages = "1--8",

journal = "International Journal of Technology Assessment in Health Care",

issn = "0266-4623",

publisher = "Cambridge University Press",

}

TY - JOUR

T1 - Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster

AU - Ruggeri, Matteo

AU - Coretti, Silvia

AU - Romano, Federica

AU - Cicchetti, Americo

PY - 2016

Y1 - 2016

N2 - XZostavax vaccine is cost effective

AB - XZostavax vaccine is cost effective

KW - Economic evaluation

UR - http://hdl.handle.net/10807/96279

M3 - Article

SN - 0266-4623

VL - 32

SP - 1

EP - 8

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

ER -

Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster

Abstract

UN SDGs

Keywords

Other files and links

Fingerprint

Cite this